Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jung Choi currently holds 33,000 shares of Global Blood Therapeutics, Inc. (GBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jung Choi has been a net seller of GBT stock. They have purchased $1.1M and sold $1.4M worth of shares.
Jung Choi's most recent insider trade was on Dec 1, 2025, when they purchased 33,000 shares at $4.19 per share.
Jung Choi serves as Executive at Global Blood Therapeutics, Inc. (GBT). They have executed 122 insider transactions totaling $2.5M over their tenure at the company.
Jung Choi holds the position of Executive at Global Blood Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Jung Choi has shown a selling trading pattern, with $1.1M in total purchases and $1.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jung Choi was on Aug 1, 2020, when they sold $421.0K worth of GBT shares. This transaction involved 6,239 shares at $67.48 per share.
Jung Choi currently owns 33,000 shares of Global Blood Therapeutics, Inc. (GBT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jung Choi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jung Choi has 122 Form 4 filings on record as an insider at Global Blood Therapeutics, Inc..
Set alerts for Jung Choi and 40,000+ other insiders.